These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 17717890)
1. Ask the doctor. Are Lipitor and Crestor equally good for me? Lee R Harv Heart Lett; 2007 Aug; 17(12):8. PubMed ID: 17717890 [No Abstract] [Full Text] [Related]
2. Statin, the black box. Hatem S; Boccara F Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149 [No Abstract] [Full Text] [Related]
3. Dramatic reductions in plaque volumes on maximum statin therapy. Cardiovasc J Afr; 2011; 22(6):344-5. PubMed ID: 22159326 [No Abstract] [Full Text] [Related]
4. Is there a "best" statin drug? Johns Hopkins Med Lett Health After 50; 2004 Jan; 15(11):4-5. PubMed ID: 14983817 [No Abstract] [Full Text] [Related]
5. Complications and side effects. Crestor tested in PHAs. TreatmentUpdate; 2005; 17(4):6-7. PubMed ID: 17230630 [No Abstract] [Full Text] [Related]
6. Update on statins. Mason P J Vasc Nurs; 2004 Jun; 22(2):49-50. PubMed ID: 15179417 [No Abstract] [Full Text] [Related]
7. Statins and the kidney: friend or foe? Campese VM Lancet Diabetes Endocrinol; 2015 Mar; 3(3):161-2. PubMed ID: 25660357 [No Abstract] [Full Text] [Related]
8. Atorvastatin for stroke prevention. Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287 [No Abstract] [Full Text] [Related]
9. Chronic kidney disease: Statins in chronic kidney disease: time to move on? Haynes R; Wanner C Nat Rev Nephrol; 2015 May; 11(5):262-3. PubMed ID: 25802077 [TBL] [Abstract][Full Text] [Related]
10. Intensive lipid-lowering therapy for patients with aortic stenosis. Pedersen TR Am J Cardiol; 2008 Dec; 102(11):1571-6. PubMed ID: 19026317 [TBL] [Abstract][Full Text] [Related]
11. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials. Wlodarczyk J; Sullivan D; Smith M Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019 [TBL] [Abstract][Full Text] [Related]
12. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study). Betteridge DJ; Gibson JM; Sager PT Am J Cardiol; 2007 Oct; 100(8):1245-8. PubMed ID: 17920365 [TBL] [Abstract][Full Text] [Related]
13. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. Fox KM; Gandhi SK; Ohsfeldt RL; Davidson MH Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
15. Concern still warranted: medication burden and persistence with lipid-lowering drugs. Polinski JM; Gagne JJ Am J Manag Care; 2009 Jan; 15(1):74-5. PubMed ID: 19146367 [No Abstract] [Full Text] [Related]
16. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia? Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585 [TBL] [Abstract][Full Text] [Related]